Clinical Trial Update: Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a multi-drug regimen (clofarabine, idarubicin, cytarabine, vincristine, and dexamethasone) in newly diagnosed or relapsed mixed phenoty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bilineal Leukemia
• Biphenotypic Leukemia
• Leukemia of Ambiguous Lineage
• Mixed Phenotype Acute Leukemia
• Mixed Phenotype Acute Leukemia Myeloid Not Otherwise Specified
• Undifferentiated Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)
• DEXAMETHASONE (Dexamethasone)
• Idarubicin (idarubicin)
• Vincristine sulfate (VINCRISTINE SULFATE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2024-03-19